CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for AnyGen Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

AnyGen Co Ltd
Rm 306 Dept Of Pilot Production
Gwangju Techno P, Gwangju 500-706
Phone: +82 627141166p:+82 627141166 GWANGJU-METROPOLITAN, 61008  South Korea Ticker: 196300196300
Business Summary
ANYGEN CO., LTD. is a Korea-based company mainly engaged in manufacture and distribution of peptides. The Company's products mainly consist of leuprorelin acetate, desmopressin acetate, and contract manufacturing organization (CMO) peptides, which are used for pharmaceuticals; custom peptides, which is used for research, and argireline, which is used for cosmetics. The Company distributes its products within domestic market and to overseas markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director Jae YilKim 57
Chief Financial Officer, Director Jin SeokPark 46
Vice President, Director Yeong YikGwon 55
7 additional Officers and Directors records available in full report.

General Information
Number of Employees: 96 (As of 12/31/2023)
Outstanding Shares: 5,937,294 (As of 3/19/2024)
Shareholders: 4,756
Stock Exchange: KDQ
Fax Number: +82 627141188


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 18, 2024